Objective: To assess the antiproliferative, proapoptotic, and antiangiogenic effects of the double-stranded RNA mimic polyinosine-polycytidylic acid (pIC) complexed with polyethylenimine [pIC(PEI)] in xenografted human leiomyomas.
Design: Heterologous leiomyoma mouse model.
Setting: University-affiliated infertility center.
Animal(s): Ovariectomized and hormone-replaced nude mice (n = 16) who received human leiomyoma fragment transplantation.
Intervention(s): Leiomyoma fragments placed in the peritoneum of 5-week-old nude female mice and treated with the vehicle (n = 8) or 0.6 mg/kg [pIC(PEI)] (n = 8) for 4 weeks.
Main outcome measure(s): The size of the leiomyoma implants, and cellular proliferation (Ki67), vascularization (PECAM), and apoptosis (OH-ends) assessed by quantitative immunohistochemical/immunofluorescent analysis of the recovered implants.
Result(s): No significant differences were observed in the size of the leiomyoma implants between groups. Vascularization and proliferation were significantly decreased, and apoptosis was increased in the [pIC(PEI)]-treated group versus control.
Conclusion(s): We hypothesize that the antiangiogenic and apoptotic effects exerted by [pIC(PEI)] might lead to a decrease in lesion size in this animal model if the compound is administered for longer periods of time. This study provides promising data on [pIC(PEI)] as a potential novel therapeutic agent against human leiomyoma.
Keywords: Angiogenesis; [pIC(PEI)]; apoptosis; leiomyoma; mouse model.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.